Loading…
Liquivape, a manufacturer of e-liquid tobacco products, was found to be distributing products that lacked required premarket authorization as "new tobacco products" under the Family Smoking Prevention and Tobacco Control Act. The company failed to comply with FDA regulations requiring e-liquid products, which are deemed tobacco products subject to FDA jurisdiction, to obtain marketing authorization before commercial distribution in the United States. The violation centered on the company's failure to secure the necessary premarket approval that has been required for newly deemed tobacco products since August 8, 2016.